CONSOLIDATED STATEMENTS OF EQUITY - USD ($)	Total	Common Stock	Additional Paid-In Capital	Retained Earnings	Non-controlling Interest	Series A Preferred Preferred stock	Series C Preferred Preferred stock
Beginning balance (in shares) at Dec. 31, 2018		40,174,821				419,859	0
Beginning balance at Dec. 31, 2018	$ 28,809,044	$ 40,175	$ 75,131,122	$ (47,800,886)	$ 1,438,213	$ 420	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share based compensation expense, total	143,063		143,063
Conversion of Series B1 Preferred stock to common (in shares)		96,160
Conversion of Series B1 Preferred stock to common	150,010	$ 96	149,914	0
Dividends on Series B and B1	(406,795)			(406,795)
Accretion of discount on Series B and B1	(560,675)			(560,675)
Net income (loss)	(5,068,995)			(4,963,564)	(105,431)
Ending balance (in shares) at Mar. 31, 2019		40,270,981				419,859	0
Ending balance at Mar. 31, 2019	23,065,652	$ 40,271	75,424,099	(53,731,920)	1,332,782	$ 420	$ 0
Beginning balance (in shares) at Dec. 31, 2019		43,395,563				419,859
Beginning balance at Dec. 31, 2019	23,102,026	$ 43,396	81,527,351	(59,246,514)	777,373	$ 420
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Purchase of shares of consolidated subsidiary	(71,171)		(71,171)
Adjustment of carrying mount of non-controlling interest	9,091,068		9,091,068
Share based compensation expense, total	163,269		163,269
Conversion of Series B1 Preferred stock to common (in shares)		2,159,278
Conversion of Series B1 Preferred stock to common	3,368,474	$ 2,159	3,366,315	0
Dividends on Series B and B1	(344,499)			(344,499)
Accretion of discount on Series B and B1	(932,003)			(932,003)
Accretion of redeemable non-controlling interest to redemption value	(10,966,349)			(10,966,349)
Net income	2,908,128			2,788,860	119,268
Net income (loss)	2,390,251
Ending balance (in shares) at Mar. 31, 2020		45,554,841				419,859
Ending balance at Mar. 31, 2020	$ 26,318,943	$ 45,555	$ 94,076,832	$ (68,700,505)	$ 896,641	$ 420